Speaker illustration

Doctor Madhu Chintala

Janssen R&D, Spring House (United States of America)

Member of:

European Society of Cardiology

Differential impact of milvexian, an investigational oral FXIa inhibitor vs apixaban and dabigatran on thrombin generation in human donor plasma in vitro

Event: ESC Congress 2022

Topic: Thrombosis, Bleeding

Session: Clinical and basic science insights in vascular disease


JNJ-9375, a novel exosite 1 thrombin inhibitor does not increase bleeding in a spontaneous gastrointestinal (GI) bleeding model in mice with a mutation of the Adenomatous polyposis coli (Apc) gene

Event: ESC Congress 2018

Topic: Thrombosis, Bleeding

Session: Platelets, haemostasis and coagulation


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb